Financing, Equity Capital Markets

Pliant Therapeutics, Inc.

06/20
|
$165.6 Million
Piper Sandler served as bookrunner for Pliant Therapeutics, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma